This is the authors' abstract. We don't add key points for this paper.
Thirty-seven patients who were treated with antineoplastic drugs for metastatic thyroid carcinoma were evaluated to determine the effectiveness of chemotherapy in this disease. All cell types were included in the series, but there was a predominance of the spindle and giant cell and medullary types. Three patients had no treatment prior to the chemotherapy, with the remainder having been treated previously by surgery,131I, and radiotherapy, either separately or in combination. A wide variety of drugs were used. Five of 37 patients had partial remission of their disease. The median duration of response is now 3+ months, with two patients still responding. Three of the five responders were treated with the new antitumor antibiotic, adriamycin. The preliminary results with this drug have encouraged us to use it as a drug of choice in a prospective protocol for the treatment of metastatic thyroid cancer, and to explore its use earlier in the course of treatment.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Gottlieb et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: